摘要
采用非创伤性冠脉再通指标,比较AMI发病后≤6小时和6～12小时静脉应用尿激酶治疗31例和非溶栓治疗59例AMI患者的冠脉再通率。结果显示AMI发病后≤6小时内给药冠脉再通率高于6～12小时内给药,但疗效相近(p>0.05),均优于非溶栓治疗组冠脉再通率(p<0.05)。提示静脉溶栓疗法可延长至AMI发病后12小时。
According to the repatency indexes of non-traumatic coronary arteries, a comparison was made between the repatency rates of coronary arteries of AMI patients treated by urate oxidase and by non-thrombolytic therapy. The results showed that the repatency rate of coronary arteries by urate oxidase was higher than by non-thrombolytic therapy. It suggested that the thrombolytic therapy might be effective by intravenous infusion within 12 hours after the attack of AMI.
出处
《临沂医学专科学校学报》
1991年第3期207-210,共4页
Journal of Linyi Medical College
关键词
心肌梗塞
尿酸氧化酶类
溶栓疗法
Myocardial infarction
Urate oxidase
Thrombolyic therapy
